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Abstract
Background: This article provides the rationale and methodology, of the first randomised controlled trial to our
knowledge designed to assess the efficacy of progressive resistance training on cartilage morphology in women
with knee osteoarthritis.
Development and progression of osteoarthritis is multifactorial, with obesity, quadriceps weakness, joint
malalignment, and abnormal mechanical joint forces particularly relevant to this study. Progressive resistance
training has been reported to improve pain and disability in osteoarthritic cohorts. However, the disease-
modifying potential of progressive resistance training for the articular cartilage degeneration characteristic of
osteoarthritis is unknown. Our aim was to investigate the effect of high intensity progressive resistance training
on articular cartilage degeneration in women with knee osteoarthritis.
Methods: Our cohort consisted of women over 40 years of age with primary knee osteoarthritis, according to
the American College of Rheumatology clinical criteria. Primary outcome was blinded measurement of cartilage
morphology via magnetic resonance imaging scan of the tibiofemoral joint. Secondary outcomes included walking
endurance, balance, muscle strength, endurance, power, and velocity, body composition, pain, disability,
depressive symptoms, and quality of life.
Participants were randomized into a supervised progressive resistance training or sham-exercise group. The
progressive resistance training group trained muscles around the hip and knee at 80% of their peak strength and
progressed 3% per session, 3 days per week for 6 months. The sham-exercise group completed all exercises
except hip adduction, but without added resistance or progression. Outcomes were repeated at 3 and 6 months,
except for the magnetic resonance imaging scan, which was only repeated at 6 months.
Discussion: Our results will provide an evaluation of the disease-modifying potential of progressive resistance
training for osteoarthritis.
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Background
A rationale for implementing progressive resistance 
training as a disease-modifying treatment for knee 
osteoarthritis
Osteoarthritis (OA) is one of the most common muscu-
loskeletal disorders in the world, affecting 9.6% of men
and 18.0% of women ≥ 60 years of age worldwide [1]. In
1997, arthritis and other rheumatic conditions cost the
United States (US) $86 billion dollars (equating to
approximately 1% of the US gross domestic product) [2].
The development and progression of OA is multifactorial,
with quadriceps weakness [3], joint malalignment [4],
obesity [5], and abnormal mechanical joint forces [6] par-
ticularly relevant to this study.
Is quadriceps weakness a cause or a consequence of knee 
OA?
Some studies conclude that quadriceps weakness is a pos-
sible preceding factor in the development of OA [7], while
other studies support the possibility that quadriceps
weakness contributes to disease progression [3]. Irrespec-
tive of the timing, once OA has developed, quadriceps
weakness reduces the ability to decelerate leg movement
and the leg is less able to absorb impulse loads transmit-
ted through the tibiofemoral joint; leading to an accelera-
tion of cartilage degeneration [3].
Medial compartment OA is associated with varus mala-
lignment, and lateral compartment OA is associated with
valgus malalignment [4]. A vicious cycle of malalignment
then exists, whereby joint malalignment worsens the
underlying excessive joint compartment forces (i.e. varus
alignment increases the medial compartment load, and
valgus alignment increases lateral compartment load in
the knee during gait [8]) which contribute to OA progres-
sion in the respective compartments [4]. Knee malalign-
ment is also considered to be a likely mediator of the OA-
obesity relationship [8], as increased loading of mala-
ligned, weakly supported joints accentuates the malalign-
ment. Tendon stiffness is directly associated with muscle
strength [9]; having stiffer tendons (less tendon elonga-
tion) improves the overall function and efficiency of the
tendon as a stabilizer of the joint. By contrast, human
studies have shown strengthening muscles (an adaptation
to progressive resistance training (PRT)) increases stiffness
and Young's Modulus in tendons around the knee joint
which reduces the risk of tendon strain, and increases
joint stability [9].
Muscle weakness may also play a role in the observed gen-
der difference in the prevalence of OA, and the impor-
tance of obesity as a risk factor for OA. Firstly,
radiographic OA is approximately twice as prevalent in
women as it is in men [10]. Secondly, obesity is consid-
ered a risk factor for the development and progression of
knee OA [8], and the association between obesity and OA
is much stronger in women than in men [11]. The
increased risk of knee OA associated with obesity appears
to be related to mechanical rather than metabolic risk fac-
tors [8,12,13]. Women are weaker than men [14] and
have lower muscle mass at all ages [15]. However, this
gender disparity is diminished when lower extremity mus-
cle strength is expressed per kilogram of muscle mass [16].
Reduced absolute and relative muscle mass in women
means that they will be mechanically disadvantaged com-
pared to men at the same absolute level of obesity or body
mass index (BMI), as they have less muscle mass/strength
to support the same body mass during standing and
ambulation.
OA is considered a chronic degenerative disorder that is
characterized by a loss of articular cartilage [17]. Due to
the avascular nature of articular cartilage, cartilage devel-
opment, maintenance and aging is dependent upon the
type and magnitude of mechanical loading [18]. Immobi-
lization or load deprivation alters the morphological, bio-
chemical and biomechanical properties of articular
cartilage [18], and ultimately results in decreases in carti-
lage thickness. More specifically, research has shown a sig-
nificant 20% decrease in animal hyaline cartilage
thickness of the femur following 11 weeks of immobiliza-
tion [19]. By contrast, intermittent hydrostatic pressure
during the early stages of OA in animals has been shown
to maintain cartilage function [18]. In addition, animal
studies have demonstrated a beneficial effect of moderate
exercise on chondral lesion severity on induced (ACL-
transected) OA [20], and strenuous wheel running exer-
cise (6–12 km/day) is associated with normal cartilage (as
opposed to fissuring, pitting, and fibrillation seen in the
articular cartilage of sedentary hamsters who lived in indi-
vidual housing without running wheels) [21]. This is sup-
ported by recent cross-sectional research revealing a
higher tibial cartilage volume with both previous (base-
line) and current (10 years after baseline assessment) par-
ticipation in vigorous activity in healthy adults with no
history of joint injury or trauma [22]. In addition, walking
was also associated with a lower risk of bone marrow
lesions [22]; which have previously been shown to be
related to knee pain and cartilage degeneration [23,24].
Specific rationale for resistance training exercise
Resistance training or strength training as it is commonly
known, has beneficial effects on cardiovascular disease,
insulin action, bone density, energy metabolism, psycho-
logical health and functional status in various elderly pop-
ulations [25,26]. To date, approximately 18 randomized
controlled trials implementing a resistance training inter-
vention in isolation have been conducted in knee OA
populations. Improving pain and disability in OA cohorts
is a common hypothesis and primary outcome in many ofBMC Geriatrics 2009, 9:1 http://www.biomedcentral.com/1471-2318/9/1
Page 3 of 10
(page number not for citation purposes)
these studies. However, changes in the underlying patho-
physiology of the articular cartilage have not been
reported in any of these trials. Based on the animal and
human data reviewed above, progressive resistance train-
ing (PRT) also has the potential to reduce OA progression
through 2 proposed pathways (see Figure 1). Increased
muscle strength and tendon stiffness secondary to PRT [9]
facilitates a strong balanced co-contraction of knee exten-
sor and flexor muscles, and may thus improve joint stabil-
ity and reduce varus and valgus instability [27-29]. In the
first pathway by improving knee joint stability, abnormal
loading and harmful forces generated during walking may
be reduced; helping to protect and prevent further carti-
lage degeneration [3,30]. In the second pathway, the
moderate controlled loading of PRT may stimulate carti-
lage synthesis [31], offsetting or delaying the changes usu-
ally seen in OA.
The purpose of this article is to provide a detailed ration-
ale and methodology of the Resistive Exercise for Arthritic
Cartilage Health (REACH) trial. By publishing the
detailed methodology prior to the final outcome publica-
tion limits the potential for publication bias.
Methods
Study Design and Setting
This study was a double-blind randomized, sham-exercise
controlled clinical trial. Ethical approval was obtained
Flow diagram detailing the rationale for implementing a progressive resistance training program for people with knee osteoar- thritis Figure 1
Flow diagram detailing the rationale for implementing a progressive resistance training program for people 
with knee osteoarthritis.BMC Geriatrics 2009, 9:1 http://www.biomedcentral.com/1471-2318/9/1
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from The University of Sydney Human Research Ethics
Committee on the 13th December 2004 (Reference No.
12-2004/2/7848) and written informed consent was
obtained from all participants. This study has been lodged
with the Australian New Zealand Clinical Trials Registry
(ANZCTR Reference No. 12605000116628). The study
was conducted at the Cumberland Campus of University
of Sydney in Lidcombe NSW Australia. MRI Scans were
performed at the Symbion Clinical Research Imaging Cen-
tre in Randwick NSW Australia.
Eligibility Criteria
Women over 40 years of age in stable health with primary
OA in at least 1 knee, according to the American College
of Rheumatology clinical criteria [32] were included. Par-
ticipants were excluded if they had secondary OA (i.e. OA
diagnosed due to trauma, surgery, or other disease proc-
ess); joint injury, injection or surgery within the past 6
months or knee joint replacement; already participated in
structured exercise more than 1 day per week during the
previous 3 months; any contraindications to exercise and/
or magnetic resonance imaging (MRI); severe functional
limitation or cognitive impairment.
Recruitment
Participants were recruited from April 2005 to December
2006 from cohorts of previous research studies conducted
at the University, articles and advertisements in local
newspapers, information talks at local community and
senior citizen centres, flyers in local businesses, and word-
of-mouth.
Medical Screening
A telephone screening questionnaire was followed by a
physician history and physical exam in potential subjects.
Intervention
Participants randomized to the intervention group per-
formed resistance training at 80% of their peak strength
using pneumatic resistance machines (K400 model,
Keiser Sports Health, Inc, Fresno, CA, USA). The exercises
included unilateral knee extension, standing hip abduc-
tion and adduction; and bilateral knee flexion, leg press,
and plantarflexion. All exercises were performed for 3 sets
of 8 repetitions (6–9 sec/repetition) with 10–15 seconds
rest between repetitions and 1–2 min rest between sets.
Maximum strength tests (1 repetition maximum or 1RM)
were performed fortnightly and a new 80% load was pre-
scribed; in between strength tests participants were pre-
scribed 3% increments in load per session as tolerated. An
intensity rating of 15–18 on the Borg Rating of Perceived
Exertion (RPE) scale [33] was considered optimal and was
used to adjust the load between 1RM measurements to
assure the intended continuous progressive overload.
Exercises and or resistance were modified daily according
to participants' symptoms. Full range of motion was uti-
lized unless limited by pain. In some participants, severe
pain throughout the range of motion required substitu-
tion of isometric exercises of particular exercises intermit-
tently during the 6 month of training.
The sham intervention was designed to closely replicate
virtually all of the elements of the active exercise condi-
tion (modality, setting, supervision, equipment, volume,
duration, frequency) with the notable exception of inten-
sity, as we hypothesized that intensity would be the criti-
cal prescriptive element leading to robust adaptations in
both proximal (muscle and tendon strength/hypertro-
phy) and distal outcomes (cartilage morphology) out-
comes.
Participants randomized to the sham-exercise group
trained on the same equipment as the intervention group
except hip adduction, and performed knee extension
bilaterally. Minimal resistance was set on the machine
(weight of bar/foot plates only) and no progression was
introduced. Exercise volume was reduced to 2 sets of 8
repetitions, using same speed as in the PRT group.
Both groups trained 3 times per week for 6 months under
supervision of an exercise physiologist at the University in
a ratio of 1:1–3. If sessions were missed due to illness or
holidays, those sessions were added onto the end of the 6
month intervention. Up to 1 month extension was
allowed to complete the 78 sessions (compliance was cal-
culated as the percentage attended out of 78 sessions
available).
Adverse events
A weekly questionnaire, administered in person or by
phone was used to monitor adverse events plus changes in
health status in all participants. A priori definition of any
musculoskeletal or cardiovascular event attributable to
testing or training (i.e. inflammatory response in knee
joint, cartilage/ligament/muscle tear, fracture, fall, angina,
etc.) were considered as adverse events [34].
Pain during a training session that was self-limited and
not considered consistent with an injury (see above) was
not considered an adverse event but may have resulted in
an adjustment of training protocol to accommodate limi-
tations. Protocol deviations or adjustments occurred for
both the sham-exercise and the PRT group. The main devi-
ation included changing from a dynamic to an isometric
form of training (maximal intensity for PRT and sub-max-
imal intensity for sham-exercise group) if the dynamic
mode was causing pain in the knee joint, reducing the
intensity for the PRT group, and/or limiting the range of
motion.BMC Geriatrics 2009, 9:1 http://www.biomedcentral.com/1471-2318/9/1
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Objectives and Hypothesis
Our objective was to determine the efficacy of PRT as a
disease-modifying intervention in women with OA.
We hypothesized that high intensity PRT would decelerate
the tibial and femoral cartilage degeneration (i.e. reduce
the rate of cartilage loss) in the knee affected most by OA
and that high intensity PRT would lead to greater
improvements in body composition, physical perform-
ance, symptoms and habitual physical activity level, com-
pared to sham-exercise.
Blinding
All participants were blinded to the investigators' hypoth-
esis as to which was the preferred group. Analysis of the
primary outcome (MRI scan of cartilage morphology) was
double-blinded at all time points. All baseline and follow-
up physical performance and self-report assessments were
performed double-blinded; except for follow-up physical
performance testing, which was single blinded (partici-
pant only). At the final assessment, participants were
required to fill-out a Completion Questionnaire without
the assessor present. This questionnaire assessed the par-
ticipants' perception of whether they felt they had been in
the "preferred group" to "modify cartilage, increase mus-
cle mass and strength, reduce pain, and improve physical
function".
Assessments
Physician screening was completed initially, followed by
an MRI scan. If subjects were eligible following their MRI
scan, the remainder of the baseline physical performance
testing was completed. Subjects were randomized at the
completion of all baseline assessments.
Primary Outcome: Cartilage Thickness
A 3Tesla MRI scan (Philips Medical Systems, Achieva 3T)
of the knee with the most severe clinical signs and symp-
toms was conducted at the Symbion Clinical Research
Imaging Centre at baseline and following the 6-month
intervention. OA cartilage morphology assessed via MRI is
a reliable and valid technique, particularly for clinical tri-
als where cartilage structure modification is an outcome
[35,36]. Depending on the size of the participant's knee,
either a SENSE Knee coil (smaller knee) or a SENSE Flex-
L coil (larger knee) was used. The same coil was used for
pre and post scanning. Prior to the commencement of the
scan, a bead was placed on the thigh, halfway between the
inguinal groove and the proximal margin of the patella
measured anthropometrically by the same observer (AL)
in all participants; this marker identified the area for the
cross sectional image of the thigh region. The scans
included a 3-Dimensional image T1 weighted gradient
echo sequence of the tibiofemoral joint (repetition time =
34 ms, echo time = 9 ms, acquisition time = 9 min, flip
angle = 25°, slice thickness = 1.4 mm, in-plane resolution
= 0.31 mm), and a spin echo sequence of a cross-sectional
slice of the thigh region (repetition time = 450 ms, echo
time = 10 ms, acquisition time = 2 min, flip angle = 90°,
slice thickness = 10 mm, in-plane resolution = 0.47 mm).
Blinded measurement of cartilage morphology involved
the segmentation of articular cartilage in the medial and
lateral tibia, and the central portion of the medial and lat-
eral femur. Any cartilage or bone associated with osteo-
phytes was excluded from segmentation. Chondrometrics
Part A: Sagittal view of right knee, arrows pointing to seg- mented (colored areas) areas of tibial cartilage (Medial =  right-hand side, Lateral = left-hand side) using Chondromet- rics software Figure 2
Part A: Sagittal view of right knee, arrows pointing to 
segmented (colored areas) areas of tibial cartilage 
(Medial = right-hand side, Lateral = left-hand side) 
using Chondrometrics software. Part B: Medial (blue) 
and lateral (green) joint surface areas representing the tibial 
bone covered with articular cartilage.BMC Geriatrics 2009, 9:1 http://www.biomedcentral.com/1471-2318/9/1
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software (see Figure 2) (Chondrometrics, Ainring, Ger-
many) was used to segment the cartilage (coefficient of
variation (CV) for cartilage thickness: medial tibia = 2.2%,
lateral tibia = 2.1%, medial femur = 2.2%, lateral femur =
1.8%; cartilage volume: medial tibia = 3.2%, lateral tibia
= 2.3%, medial femur = 3.9%, lateral femur = 1.6%).
Datasets were analyzed in pairs, and the person responsi-
ble for segmenting each scan (AL) was blinded to the par-
ticipants ID number and the timepoint of the scan.
Quality control of all segmentations was performed by a
single person (BV), reviewing all segmented slices of each
data set. In addition, automatic quality control proce-
dures were used to exclude mislabelling of medial versus
lateral cartilage plates, tibial versus femoral cartilage
plates and cartilage versus total subchondral bone con-
tours, the software checking the distance vectors between
different plates/contours and a fibular marking. Follow-
ing cartilage segmentation, computations performed by
Chondrometrics software provided outputs for medial
and lateral tibial and femoral total subchondral bone
area; denuded area (area of subchondral bone eroded, full
thickness defect); mean thickness (mean cartilage thick-
ness over total subchondral bone area), thickness covered
(mean cartilage thickness over cartilage-covered subchon-
dral bone area), cartilage volume, and VCtAB (volume of
cartilage divided by total subchondral bone area).
The outputs for each compartment were analyzed sepa-
rately; and compartments were also combined, i.e. total
tibial cartilage volume (medial + lateral) =
The same equation applied for total femoral cartilage vol-
ume. Total medial compartment volume (medial femoral
volume plus the medial tibial volume) was calculated,
and the same equation applied for the total lateral com-
partment volume.
In addition to total compartment analysis, participants
were categorized into both geographical OA (medial, lat-
eral, or bi-compartmental) and also, the least and most
affected compartment based on MRI Grade classification
and osteophytes.
Image J software (Image J software v 1.37, Wayne Ras-
band, http://rsb.info.nih.gov/ij/) was used to calculate
muscle and fat volume by a single blinded assessor (CV
muscle = 0.16%, fat = 0.2%).
Two blinded physician assessors conducted baseline clin-
ical musculoskeletal system evaluation and MRI interpre-
tation (OA graded according to the MRI correlation of the
Modified Outerbridge Classification 1961) at baseline
and 6 months independently of each other.
Secondary Outcomes
Dynamic muscle strength
Lower extremity peak strength was assessed using digital
K400 Keiser pneumatic resistance machines (Keiser Sports
Health Equipments, Inc., Fresno, CA). One repetition
maximum (1RM) tests were performed according to de
Vos and colleagues [37] unilaterally on knee extension,
hip abduction and adduction; and bilaterally on knee
flexion, leg press, and plantarflexion. Strength tests were
performed twice at baseline approximately 1 week apart,
and the higher of the 2 results was recorded as the 1RM.
The mean (range) CV for the 9 exercises in this cohort was
13.1 (9.8–21.7) %.
Muscle Contraction Velocity
Peak muscle contraction velocity was assessed in a non-
fatigued state on a separate day, several days after their
final strength test. The test was performed at 20% baseline
1RM on Keiser resistance machines: unilateral knee exten-
sion, and bilateral knee flexion and leg press [37].
Muscle Endurance
Muscle endurance was assessed after resting from velocity
testing. Participants were instructed to perform as many
consecutive repetitions as possible at 90% of their base-
line 1RM through their full range of motion in correct
form. The test was terminated if correct technique was not
achieved, a visible pause occurred, or the participant
began experiencing significant pain in their knee joint.
Number of repetitions, along with mean work, velocity
and power were recorded for the first repetition and the
last correct repetition. The ratio of last/first repetition
power was used as an index of fatigue.
Muscle velocity and endurance were performed during the
first training session, with loads based on the higher of the
1RM values obtained. Follow-up endurance testing was
conducted using the same 90% 1RM load used during
baseline testing.
Physical Performance
Walking Endurance
The 6-minute walk test, performed according to Guyatt
and colleagues [38] was used to assess walking endurance
to the nearest 0.1 m. The better of 2 trials 1 week apart was
recorded. The CV in this cohort was 3.0 (0.0–13.0) %.
Balance
The Chattecx Dynamic Balance System (software version
4.20; Chattecx Corp, Chattanooga Group Inc., Hixson,
TN) was used to assess balance. This system allows testing
of static balance time and body sway via measurements
from the force platform [39]. Three test conditions were
performed with eyes open and with eyes closed in a ran-
dom order and without prior practice: i) narrow bilateral
(Total tibial volume at baseline Total tibial volume at 6  − m months
Total tibial volume at baseline
)
×100BMC Geriatrics 2009, 9:1 http://www.biomedcentral.com/1471-2318/9/1
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stance on the platform sliding backward and forward at a
speed of 8.3 s/cycle in the anterior-posterior direction; ii)
narrow bilateral stance on the platform tilting up and
down from 0 to ± 2 degrees in the anterior-posterior direc-
tion; and iii) unilateral stance of the preferred leg on still
platform. Balance was tested for up to 30 seconds per test.
A maximum of 3 trials was allowed to complete each test
if participants lost their balance (touching hand rails, tak-
ing a step off the platform, requiring support from the
assessor). If no attempt was successful, the trial with the
longest time was recorded and only data from this trial
was analyzed. Unilateral stance duration with eyes closed,
summated maximum sway in 4 directions (medial, lat-
eral, anterior and posterior), and number of trials needed
to complete the 6 conditions were used as individual
measures of balance performance.
Overall balance performance was examined using a bal-
ance index [40]. The balance index was calculated by sum-
mating all anterior-posterior and medio-lateral sway
measures and time results respectively.
This index has been shown to be reliable and valid, and is
sensitive to change over time with an exercise intervention
in older adults [40].
Stair climb
Maximal stair climb was used as a proxy for lower extrem-
ity power [41]. Two trials were conducted of the 9-step
stair climb with 30–60 seconds rest between each trial.
The best of the 2 test results was used. Stair power was cal-
culated according to the formula below [41,42]:
Chair stand
Five chair stand test, performed according to Guralnik and
colleagues [43] was used as an index for lower extremity
power/balance. Time taken, as well as number of stands
completed was recorded. The need for assistance from
armrests was also recorded (yes or no) and analyzed as a
separate outcome.
Gait Velocity
Gait analysis was performed using a 10-camera Motion
Analysis system (Motion Analysis, Santa Rosa, California)
set to sample at 100 Hz. Thirty-eight passive reflective
markers were placed bilaterally on standard bony land-
marks of the lower and upper body. Participants were
asked to walk barefoot without any assistive devices at
their self-selected normal and maximal speed for 5 trials.
Gait velocity was defined as the mean horizontal velocity
of the sacrum marker during 2 full strides and was aver-
aged over 5 trials. The CV in this cohort of the 5 trials was
4.6 (0.7–12.5)%.
Body Composition
Body mass index was calculated from fasting weight and
stretched stature measurements [44]. Waist circumference
was measured according to the International Diabetes
Federation protocol [45]. Percent body fat and fat-free
mass were estimated using bioelectrical impedance (BIA-
101: RJL Systems, Detroit, MI) All participants were meas-
ured 3 times early in the morning after a 12-hour fast. The
CV in this cohort for resistance was 0.03 (0.0–0.1)%. Fat
mass and fat-free mass were calculated from the formula
developed by Lukaski and colleagues for older adults [46].
Questionnaires
All questionnaires were interviewer-administered in a pri-
vate room using visual prompts.
Symptomatology and disability was assessed using the
Western Ontario and McMaster Osteoarthritis Index
(WOMAC) questionnaire [47]. Habitual physical activity
levels were assessed using the Physical Activity Scale for
the Elderly (PASE) questionnaire [48] and Harvard
Alumni Questionnaire [49]. Depressive symptoms were
assessed using the Geriatric Depression Scale (GDS) [50].
Physical self-efficacy was assessed for lifting objects, walk-
ing, jogging, climbing stairs, and doing push-ups using
the Ewart Self-Efficacy scale [51]. Health-related quality of
life was assessed using Version 2 of the Medical Outcome
Survey 36-item Short-Form (SF-36) [52]. All question-
naires have been well validated in OA and elderly cohorts.
Covariates
Covariates identified a priori included age, BMI, duration
of OA, use of glucosamine and/or chondroitin sulfate,
number of chronic diseases. Other covariates will be
selected if potential confounders are identified amongst
baseline participant characteristics.
Definitions
Session compliance was defined as the number of sessions
attended out of 78 available sessions (up to 1 month
extension was given to make up any missed sessions dur-
ing the 6-month intervention). Training intensity compli-
ance was defined as the difference between the theoretical
relative load and the actual relative load for exercise for
each session. The theoretical relative load (relative to the
most recent 1RM) and the actual relative load was calcu-
lated at 4, 8, 12, 16, 20, 24, and 26 weeks. The actual load
was then subtracted from the theoretical relative load to
get difference in relative loads. Difference should be equal
to zero if training intensity compliance was perfect or the
results will be negative if actual was greater than theoreti-
cal. A one sample t-test was then performed to see whether
Power (W)
Body Weight (N) Height of Stairs (m)
Ascent Time
=
×
   s ()BMC Geriatrics 2009, 9:1 http://www.biomedcentral.com/1471-2318/9/1
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or not the difference in loads was significantly different
than "zero", the ideal value.
Total tonnage per exercise was calculated by summating
the training load by the number of repetitions completed
for that exercise for the intervention (24 repetitions for 78
sessions (total of 1872 repetitions) per exercise for the
PRT group and 16 repetitions for 78 sessions (total of
1248 repetitions) per exercise for the sham-exercise
group).
Whole body total tonnage was calculated by summating
the total summated loads of each exercises and multiply-
ing that by the total number of repetitions of all exercises.
Dropouts were those participants who did not complete
the intervention and did not complete their final assess-
ment (i.e. loss to follow-up). Discontinued subjects were
those who did not complete the intervention, but did
complete their final assessment and were included in the
complete case analysis.
Sample Size
Reginster and colleagues [53] conducted an RCT of glu-
cosamine vs. placebo in patients with OA, and reported
no loss in joint space width (mean -0.06 mm) in the glu-
cosamine group vs. a -0.31 mm joint space loss in the pla-
cebo group (p = 0.043). Radiographic joint space loss has
been shown to be closely related to reduction in cartilage
thickness by MRI, our primary outcome [54]. We conserv-
atively assumed, given the lack of published data, that the
protective effect of PRT would be 20% less than that of
glucosamine (i.e. 80% rather than 100% reduction in car-
tilage loss). Therefore, our sample size was estimated from
the expected rate of cartilage thinning in sedentary
patients with OA of -2.8 ± 2.7% per 6 months [55], which
we hypothesized would be unchanged by sham exercise in
the controls but would be reduced by 80% to -0.56 ± 2.7%
by PRT exercise. The sample size was inflated by 20% to
accommodate the anticipated dropout rate over 6
months, based on previous exercise and OA trials in the
literature and in our experience. Therefore, the final sam-
ple size targeted was 63.
Randomization
Using a computerized randomization program http://
www.randomization.com, a co-investigator uninvolved
in participants testing or training randomly allocated par-
ticipants into 1 of 2 groups. Participants were stratified
according to glucosamine and/or chondroitin use (cur-
rent or within the past 6 months) and Physical Function
(Section C; Disability) WOMAC score (< or > 27) in order
to equalize these potential confounders between groups.
After completion of baseline assessments, participants
were given a sealed envelope containing the allocated
group (A or B) in accordance with the randomization
sequence.
Statistical analysis
Data were inspected for normality visually and statisti-
cally (skewness -1 ≥ 1), and expressed as mean and stand-
ard deviation or median and range, as appropriate. Non-
normally distributed data were log-transformed prior to
use with parametric statistics if possible or used with non-
parametric tests if assumptions of normality were not met
despite transformation. Our primary analytic strategy was
a complete case analysis because of the novelty of our pri-
mary outcome. Our secondary sensitivity analysis was
intention-to-treat with data imputed via the expectation
maximization algorithm (covariates included in the
model were group, baseline score, and compliance).
Comparisons between groups were made using repeated
measures analysis of co-variance (ANCOVA) for both
time and group × time interactions, and ANCOVA models
for % change scores adjusted for baseline value of each
outcome for normally distributed continuous data. Addi-
tional covariates considered for inclusion in these models
were characteristics at baseline which were different
between groups and related to the dependent variable of
interest. The Kruskal-Wallace test or Mann-Whitney U test
were used for non-normally distributed continuous data.
SPSS (Release 13.0 for Windows, 2004, Chicago: SPSS
Inc) was used for all data analysis. All P values of less than
0.05 were considered statistically significant except for
post-hoc comparisons of pairs of variables from signifi-
cant Kruskal-Wallace models, which were adjusted for
multiple comparisons using the method of Bonferroni.
Clinical meaningfulness of differences observed was
assessed by evaluation of the magnitude of the differences
relative to clinical outcomes in the literature, and calcula-
tions of effect sizes (Formula 1) adjusted via Hedges bias-
corrected effect size for small sample sizes [56]. Effect
sizes were interpreted according to Cohen's interpretation
of 'trivial' ( < 0.20), 'small' (≥ 0.20 < 0.50), 'moderate' (≥
0.50 < 0.80), and 'large' (≥ 0.80) effect size [56]. Caution
was taken when using Cohen's interpretations as these
were originally based on psychological studies. 95% con-
fidence intervals (CIs) for the relative ES were calculated.
Discussion and conclusion
Our primary outcome results of cartilage morphology are
anticipated in July 2009. This information will provide
the first evidence for the efficacy of PRT as a disease-mod-
ifying treatment for OA of the knee. Our robustly
designed study will be one of very few OA studies that
conform to all CONSORT requirements for the reporting
of RCTs [57]. In addition, the REACH study will be the
Effect Size
 Treatment  Control
Pooled SD
Formula  =
− ΔΔ
(; ( ) ) 15 6BMC Geriatrics 2009, 9:1 http://www.biomedcentral.com/1471-2318/9/1
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first RCT to provide information on the feasibility of using
a sham-exercise control group in OA clinical trials.
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